August 2008
You realize that its been just a little too quite tonight when the radio
suddenly cackles to life: Teenage girl... asthma cant breathe
diaphoretic giving nebs No IV 2-minute ETA. Within minutes,
two medics rush in with a diaphoretic cyanotic girl perched forward on her
hands. Her pleading glance catches yours as you watch her take her last
voluntary breath; intubation is obviously required ventilator management
is your concern since you realize her life depends on it .
As you resuscitate the crashing asthmatic, your 60-year-old male patient
on the other side of the curtain, who has been sleeping comfortably, begins
to complain that his breathing is getting worse. He is a frequent flyer with
a known history of bad emphysema and a worse attitude. He adamantly
refuses the mask ventilation. You think back about his chest x-ray, which
showed extensive bilateral pulmonary infiltrates, and wonder how long
your luck can hold up before you need to intervene with him. His voice
and attitude sound oddly weak, but you remember that the last time he was
intubated he developed a pneumothorax .
Just as you ponder these thoughts, a seasoned pair of medics burst
into the ED. The hiss of nebs can be heard under the rushing sound of
high pressure CPAP. Sorry Doc, tried to raise you on the radio but no
one answered. This lady is sick and not moving much air. We got her on
CPAP at 20, 100%, but were not making much progress; heart rate of 170
and cant get her sats higher than 60%. Shes got CHF. Had no time to
intubate. Just then their short, morbidly obese, pale, diaphoretic patient
Editor-in-Chief
Editorial Board
William J. Brady, MD
Professor of EM and Medicine Vice
Chair of EM, University of Virginia,
Charlottesville, VA
Peter DeBlieux, MD
Professor of Clinical Medicine,
LSU Health Science Center;
Director of EM Services, University
Hospital, New Orleans, LA
Wyatt W. Decker, MD
Chair and Associate Professor
of EM, Mayo Clinic College of
Medicine, Rochester, MN
Francis M. Fesmire, MD, FACEP
Director, Heart-Stroke Center,
Erlanger Medical Center; Assistant
Professor, UT College of Medicine,
Chattanooga, TN
Michael White, MD
Director, Department of Emergency Medicine, Shands Lake
Shore Hospital, Lake City, FL
Peer Reviewers
Peter DeBlieux, MD
Professor of Clinical Medicine, LSU Health Science Center;
Director of EM Services, University Hospital,
New Orleans, LA
Michael F. Murphy, MD
Professor and Chair, Department of Anesthesia; Professor
Emergency Medicine, Dalhousie University,
Halifax, Nova Scotia, Canada
Scott D. Weingart, MD
Assistant Professor, Director, Division of Emergency
Department Critical Care, Department of Emergency
Medicine, Mount Sinai School of Medicine, New York, NY
CME Objectives
Upon completion of this article, you should be able to:
1. Describe the management of mechanical ventilation as
it applies to asthma, emphysema, and acute pulmonary
edema.
2. Summarize basic lung mechanics and how they provide
insights into the pathophysiology of the lungs.
3. Describe the role of ventilator graphics and waveforms
as tools for detecting adverse effects of mechanical
ventilation.
4. Identify common pitfalls associated with mechanical
ventilation.
Date of original release: August 1, 2008
Date of most recent review: June 11, 2008
Termination date: August 1, 2011
Time to complete activity: 4 hours
Medium: Print & online
Method of participation: Print or online answer form
and evaluation
Prior to beginning this activity, see Physician CME
Information on the back page.
International Editors
Valerio Gai, MD
Senior Editor, Professor and Chair,
Department of EM, University of
Turin, Turin, Italy
Accreditation: This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of Mount Sinai School of Medicine and Emergency Medicine Practice. The Mount Sinai School of
Medicine is accredited by the ACCME to provide continuing medical education for physicians. Faculty Disclosure: Dr. White, Dr. DeGiorgi, Dr. DeBlieux, and
Dr. Weingart report no significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.
Dr. Murphy is a shareholder in The Airway Site. Commercial Support: Emergency Medicine Practice does not accept any commercial support.
Emphysema
Emphysema is a disease characterized by the
destruction of elastic fibers in lung tissue and the
alveolar septal wall. These changes lead to decreased
lung compliance secondary to reduced elastic
recoil. For this reason, the lungs do not return to an
appropriate resting volume at the end of exhalation.
Air that is not dynamically moved during ventilation
acts as functional dead space. The narrowing of the
smaller airways in conjunction with diminished elastic
recoil leads to atelectasis and can further increase
residual lung volumes.
Emphysema, and chronic obstructive pulmonary
disease (COPD) in general, continues to be a leading
cause of morbidity and mortality in the United States.8
The numbers related to this disease are staggering:
12.1 million people age 25 and older were diagnosed
with COPD in 2001,9 there were 1.5 million ED visits
in 2000,10 and there were 119,000 deaths in that year
alone.11 COPD is the fourth leading cause of death in
the United States and is projected to be the third leading
cause of death for both males and females by the year
2020.11 The total estimated cost of COPD in 2002 was
$32.1 billion.12 Medicare expenses for COPD patients
were nearly 2.5 times that of the expenditures for all
other patients.12
Epidemiology
Asthma
Asthma is an obstructive process associated
with significant airway resistance secondary to
bronchospasm, increased mucous production, edema,
inflammation of the mucosal lining, and plugging of
the bronchi and bronchioles. The energy required to
Emergency Medicine Practice 2008
Basics Of Breathing
When a person inspires, the diaphragm contracts and
pulls the lungs downward. This produces negative
pressure within the alveoli that is transmitted to
the airway; air is then drawn in. During expiration,
passive relaxation of the chest wall musculature allows
the chest cavity to naturally recoil to elastic neutrality.
Between each regular inhalation and exhalation,
there is a brief expiratory pause when intrathoracic
pressures match atmospheric pressures. This process
is referred to as spontaneous negative pressure
breathing. Ventilator breathing is markedly different
in that ventilated lungs have air pushed rather than
drawn into them. This is referred to as positive
pressure ventilation. Positive pressure ventilation can
be provided invasively (as when a patient is intubated
and on full ventilatory support) or non-invasively
(continuous positive airway pressure [CPAP] or bilevel positive airway pressure [BiPAP]).
Mechanical Ventilation
Intrapulmonary Shunt
Alveolar Collapse
Decreased V/Q ratio
Blood
Blood is shunted from the right to the left side of the heart
as it passes lung tissue without gas exchange.
Uncontrolled arrhythmias
Altered level of consciousness
Poor patient cooperation
APACHE II score > 29
Glasgow Coma Score < 11
Respiratory distress persists after 2 hours of NPPV
Hemodynamic impairment requiring vasoactive drugs38
Volume
control
AutoPEEP
Intrinsic PEEP
CPAP
Continuous
positive
airway
pressure
E-Time
Expiratory
flow
FIO2
Fraction of
inspired
oxygen
I:E Ratio
Inspiration to
expiration
ratio
I-Time
Inspiratory
time
Mode
The mode in mechanical ventilation describes how
the ventilator controls pressure, volume, and flow
for each breath, along with a description of how the
breaths are sequenced.39 No evidence conclusively
proves one mode of ventilation provides a better
outcome than another for initial management of acute
respiratory failure. The principles of ventilation are
more important than the mode used to practice them.
The most commonly used mode is assist/control.
Assist/control covers both aspects of volume control
(AC) and pressure control ventilation (PC/AC).
During AC, the ventilator will deliver a set
number of breaths at a preset tidal volume (in volume
control mode) or pressure control level (in pressure
control mode, adjustments in pressure are necessary
until the desired expired volume is achieved). In the
absence of a patients spontaneous effort, the ventilator
will deliver the controlled breaths. This approach
ensures a minimum level of minute ventilation. A
set respiratory rate is compulsory for an adequately
sedated and possibly paralyzed patient since the
ventilator does all the work.
PBW
Predicted
body weight
PC/AC
Pressure
control
PEEP
Positive endexpiratory
pressure
PIP
Peak
inspiratory
pressure
Pplat
Plateau
pressure
RR
Respiratory
rate
VE
Minute
ventilation
VILI
Ventilatorinduced lung
injury
VT
Tidal volume
Terminology
The most common abbreviations, acronyms, and
terminology associated with mechanical ventilation are
listed in Table 2.
General Approach
A framework for remembering the basics of ventilator
management is provided by the mnemonic: MOVE
AIR.
M = Mode
O = Oxygen
V = Volume (VT) or Pressure (PC)
E = Expiratory PEEP
A = Adequate Sedation
I = Inspiratory Time
R = Rate
Oxygen
Oxygen saturation should be maintained > 90%. The
concentration of oxygen delivered is adjusted by
changing the FIO2 (fractional percentage of oxygen)
from 21% (room air) to 100%. An arterial blood gas
(ABG) will calculate the initial partial pressure of
Pressure Control/Assist Control (PC/AC) (Figures 3 and 4)
oxygen (PaO2) and the arterial partial pressure of
A pressure-controlled breath provides a constant
carbon dioxide (PaCO2). These values can be correlated
preset pressure. In this mode, the tidal volume (VT),
to noninvasive end tidal CO2 and pulse oximetry to
rather than the airway pressure, is variable. Flow is
allow for a noninvasive means of guiding ventilator
variable as well, as the ventilator delivers as much as is adjustment. It is reasonable to adjust FIO2 according
needed to achieve the preset pressure limit. Therefore, to the pulse oximeter as long as a good waveform is
volume and flow will change based on the patients
available and corresponding correctly with the rhythm
lung compliance and airway resistance. Pressure
strip and ABG. A reasonable goal is to reduce the
is set with a target volume in mind. The volume is
delivered oxygen concentration to < 50%.40
only a target because, unlike volume control, the
VT may be higher or lower than intended. On the
Volume/Pressure (Figure 5)
alarm settings, the tidal volume parameters are set
Volume or, more specifically, tidal volume (VT) is
above and below this target volume so the alarm
the amount of gas the ventilator delivers during each
will sound if the patients volumes are outside of the
Figure 4. Overview Of Settings: MOVE AIR
desired range. As opposed to volume control mode,
where the ventilator is set to alarm for high pressures,
in pressure control mode, setting a low and high VT
MODE
ASSIST CONTROL
limit will serve as an alert to inappropriate changes in
volume delivered as a result of dynamic alteration in
the patients lung mechanics.
Volume
Pressure
As an aside, synchronized intermittent mandatory
Control
Control
RATE
ventilation (SIMV) is a form of assist control where
the ventilator is programmed to deliver a set number
of breaths at either a predetermined tidal volume or
pressure control level. SIMV allows the patient to
Figure 2. Flow In Volume Control Mode
I-time
% I-time
Flow
FLOW IS CONSTANT
Flow
(L)
SET
ACTUAL
TIDAL
VOLUME
SET PC
FOR
TARGET
VT
I-time
% I-time
FIO2
21%100%
PEEP
Time
Volume Control Mode
FLOW VARIES
Pressure
PIP
Flow
(L)
Causes
Decreased Compliance
Increased Resistance
Increased Flow
Increased Volume
Time
PEEP
Time
Respiratory Rate
During the initial management of a fully sedated
ventilated patient, the respiratory rate is determined by
Figure 6: Lung Compliance
Compliance (C)
C = Tidal Volume
PplatPEEP
Pressure (PC/AC)
Minute ventilation VT x RR
VT delivered x RR
Flow
Constant
I-time
Constant
Constant
Decreased
Compliance
Volume constant
PIP increases
Pressure constant
VT decreases
Increased
Resistance
Volume constant
PIP increases
Pressure constant
VT decreases
Strengths
Known tidal
volume
Known minute
ventilation
Weaknesses
Uncontrolled PIP
may increase
risk for VILI
No guarantee of tidal
volume
Controlling pH
and pCO2
Adjust minute
ventilation by
either VT or RR
Controlling PaO2
DECREASES WITH:
Pulmonary edema Dynamic hyperinflation
Consolidation
Tension pneumothorax
Atelectasis
Mainstem intubation
Overdistention
ARDS
Pulmonary fibrosis
Press
Plateau
Pressure
Time
EXPIRATORY Occlusion Maneuver
auto-PEEP: Expiratory pause for at least 3 seconds
during the exhalation phase. PEEP must be turned
to zero for accurate results. In a normal subject,
alveolar pressure is nearly zero. When air trapping is
present, the pressure difference associated with the
trapped volume is auto-PEEP.
Press
Prolong E-time
VE = VT x RR
Expiratory
Pause
auto-PEEP
Time
Rate
Reduced respiratory rates and shortened I-times will
allow longer exhalation times, reduce air trapping, and
help minimize VILI caused by alveolar overdistention.48
Adjusting inspiratory time versus reducing respiratory
rate is summarized in Table 4. Prolongation of
expiratory time has been shown to decrease dynamic
hyperinflation in patients with severe asthma; this was
demonstrated in an observational study by Leatherman
et al of 12 mechanically ventilated patients.59 The
reduction in respiratory rate allowed for longer
E-times, and the decrease in dynamic hyperinflation
was evidenced by a reduction in plateau pressure. This
is accomplished by beginning with a rate between 6
bpm and 8 bpm with the main goal of ensuring low
minute ventilation (VE) and an expiratory time long
enough to allow lung emptying; lung emptying is
observed on the flow verses time waveform on the
ventilator. The expiratory flow waveform optimally
should return to baseline before the next breath begins
(Figure 10).
Finally, auscultation of the intubated asthmatic
is critically important. While the ventilator can
offer significant information, listening for complete
expiration (end of wheezing) before the next breath
begins is paramount to preventing air trapping and
dynamic hyperinflation.
PEEP
The presence of air flow at end-expiration indicates
that the alveolar pressure is higher than the applied
PEEP.44 The challenge at the bedside is to select the
appropriate amount of PEEP to counterbalance autoPEEP (also called intrinsic PEEP). To do this, autoPEEP must be determined by the expiratory occlusion
maneuver (Figure 8). PEEP can have a significant
positive effect in the care of an asthmatic and should
not be overlooked. Well-designed prospective studies
of over 60 patients have shown that the addition
of PEEP in the setting of auto-PEEP will prevent
gas-trapping by holding the airways open.6062 The
appropriate use of PEEP will provide alveolar stability
and reduce potential injury that occurs during
recruitment and decruitment of atelectatic alveoli.63
However, PEEP levels of 10 cm H2O or higher can
increase lung volume in patients with asthma and lead
to lung overdistention.64 The use of PEEP during total
Tidal Volume
Since the most effective method of decreasing dynamic
hyperinflation is by reducing the minute ventilation
Figure 10. Air Trapping On Flow Wave Form
(VE = RR x VT), patients with asthma will benefit from
Air Trapping Versus Prolonged Exhalation
reduced tidal volumes. Protective lung ventilation
starts at 6 mL/kg predicted body weight (PBW) and
Flow
increases to 810 mL/kg PBW as long as the plateau
I-time too short
L/min
58
pressure remains < 30 cm H2O. Similarly, if the
plateau pressure is above 30 cm H2O at a VT of 6 mL/
Longer E-time
kg PBW, then VT should be decreased to 45 mL/kg
to keep the plateau pressure below 30 cm H2O. This
strategy will minimize the potential of developing VILI
Time
injury.
Flow returns to
baseline
Emphysema
The loss of elastic recoil differentiates emphysema
from asthma. Patients with emphysema experience
both airway collapse and flow limitation during
normal tidal breathing.45,65
Since elastic recoil of the lungs is key to outward
flow of air, emphysematous patients have prolonged
expiratory times and reduced outward flow. If the
tidal volume is not completely exhaled, then a certain
amount of air will be trapped in the alveoli. On x-ray,
this hyperinflated lung appears lucent and is the
characteristic picture for a COPD patient or the pink
puffer. The functional residual capacity (FRC) is the
volume of gas remaining in the lungs at the end of
normal exhalation; it is increased in this population.
The overall result of all these effects is increased
dead space, severe ventilation-perfusion mismatch
related to atelectasis, marked airflow limitation
(bronchospasm, mucus, edema), air trapping (autoPEEP), and hyperinflation (alveolar overdistention).66
Dynamic hyperinflation has the most deleterious
effects, such as decreased cardiac output and increased
risk of barotrauma.6771 Therefore, when managing
a decompensated emphysematous patient on a
ventilator, close attention must be paid to managing
dynamic hyperinflation. This can be achieved by a
combination of reduced respiratory rates (prolonged
expiratory times), limited tidal volume, and shortened
I-times.
Rate
Acute respiratory failure in patients with emphysema is
associated with significant expiratory obstruction and
hyperinflation. Decreasing the amount of auto-PEEP on
mechanical ventilation requires a decreased respiratory
rate and prolonged expiratory phase. Since these
patients often have less structural airflow obstruction
than patients with asthma, initial rate settings can begin
at 1012 bpm. An end-expiratory occlusion maneuver
should then be performed to measure auto-PEEP (air
trapping). The exhalation phase can be expanded by
decreasing the mechanical respiratory rate or shortening
the I-time (Table 4).
An increase in respiratory rate proceeded by a
decrease in expiratory time will worsen dynamic
hyperinflation.
PEEP
PEEP provides a fixed positive airway pressure at the
end of expiration and opens previously unrecruited
alveolar units. In the case of auto-PEEP due to flow
Tidal Volume (VT)
On a ventilator, progressive hyperinflation results from limitation, increasing the PEEP setting on the ventilator
either excessive tidal volume or insufficient expiratory should be set to counterbalance the auto-PEEP based on
individualized lung mechanics.6264,73 In emphysema,
time. Overinflated alveoli will increase dead space;
the different parts of the lungs are not affected to the
this increases residual air within the lungs, reduces
exchange of gases, and lowers alveolar ventilation. VT same degree. Certain lung units may have longer
time constants and therefore be more predisposed to
Table 4. Adjusting I-Time Versus Respiratory Rate
hyperinflation than others.74 This increases the intricacy
of determining optimal PEEP levels. Unfortunately,
Example: RR: 10 breaths per minute
there is insufficient data to support a generalized PEEP
Total Cycle Time: 6 seconds (60 seconds divided by 10 breaths
setting to prevent or minimize ventilator-associated
= 6 seconds/breath)
lung injury while simultaneously preventing alveolar
I-time = 1.0 seconds
collapse. Evidence-based data is lacking to prove that
E-time = 5.0 seconds
high levels of PEEP are better.
I:E ratio = 1:5 (expiratory time divided by
inspiratory time)
RR:
Decreasing
I-Time
Decreasing
Respiratory Rate
Decreased to 6
breaths per minute
6 seconds
10 seconds
I-Time:
Decreased to 0.75
seconds
E-Time:
I:E Ratio:
1:7
1:9
Normal Lungs
Time
EMPHYSEMA:
INITIAL VENTILATOR SETTINGS
MODE: Pressure Control or Assist Control
If PC, set PC for target tidal volume desired
If AC, set actual tidal volume
FIO2: 1.0
RR: 1012 bpm
VT: 8 mL/kg PBW
PEEP: auto-PEEP measurement on PEEP of 0
NO
YES
Patient requires
more sedation and
analgesia.
Consider
increased
sedation/paralysis.
Key:
FIO2: Fraction of Inspired Oxygen
VT: Tidal Volume
RR: Respiratory Rate
PEEP: Positive End-Expiratory Pressure
Pplat: Plateau Pressure
PC: Pressure Control
AC: Assist Control
PULMONARY EDEMA:
INITIAL VENTILATOR SETTINGS
MODE: Pressure Control or Assist Control
If PC, set PC for target tidal volume desired
If AC, set actual tidal volume
FIO2: 1.0
RR: 1214 bpm
VT: 8 mL/kg PBW
PEEP: auto-PEEP measurement on PEEP of 0
YES
NO
Is auto-PEEP present?
YES
NO
Set
PEEP to
5 cm H2O
(Class IIb)
Is CO2 80?
Is PH 7.20?
(Class Indeterminate)
YES
Wean FIO2 to maintain PaO2
6080 mm Hg
Continue aggressive medical
therapy
Monitor therapy goal
(Class IIa)
NO
Decrease VT but not
< 45 mL/kg
Decrease PC to
decrease target VT
(Class I)
NO
Consider increasing RR if absence of air
trapping
May increase VT to 810 mL/kg if plateau
pressure is < 30 cm H2O
Consider methods of decreasing carbon
dioxide production, such as fever control
(Class IIb)
The evidence for recommendations is graded using the following scale: Class I: Definitely recommended. Definitive, excellent evidence provides
support. Class IIa: Acceptable and useful. Very good evidence provides support. Class IIb: Acceptable and useful. Fair to good evidence provides
support. Class III: Not acceptable, not useful, may be harmful. Indeterminate: Continuing area of research.
This clinical pathway is intended to supplement, rather than substitute, professional judgment and may be changed depending upon a patients
individual needs. Failure to comply with this pathway does not represent a breach of the standard care.
Copyright 2008 EB Practice, LLC. 1-800-249-5770. No part of this publication may be reproduced in any format without written consent of
EB Practice, LLC.
10
FIO2
Oxygen therapy provides benefits to patients who are
hypoxemic. Oxygen should be administered in doses
sufficient to raise the partial pressure of oxygen greater
than 60 mm Hg8 or a pulse oximeter reading greater
than 90%. The risk of oxygen-induced respiratory
acidosis and hypercapnic respiratory failure associated
with COPD is no longer a concern once the patient
is intubated, sedated, and on controlled mechanical
ventilation. However, prolonged use of high oxygen
concentrations can lead to alveolar-capillary membrane
changes and absorption atelectasis.75 Set the FIO2 at
100% upon the initiation of mechanical ventilation, and
wean as early as possible to avoid extended uses as
long as adequate serum partial pressure of oxygen is
maintained.
11
Alveolar Overdistention
Normal physiologic VT is typically around 68 mL/
kg PBW throughout life. Until recently, most patients
with acute respiratory failure were managed with
VT of 1015 mL/kg PBW. VILI can occur when the
lungs and alveoli overdistend.85 It is quite clear in the
evidence of 2 randomized, controlled trials of over
900 patients60,86 that VT 12 mL/kg PBW in acutely
ill patients is associated with increased mortality and
that smaller tidal volumes of 68 mL/kg PBW were
effective in the management of acute lung injury as
they avoided excessive alveolar distention. Along
similar lines, patients with obstructive and restrictive
processes who are at risk for VILI may also benefit
from lung-protective ventilation.87,88 However, there
is insufficient data to recommend a VT of 6 mL/kg
PBW as a standard for every patient who requires
mechanical ventilation.
Plateau pressures are determined by static
measurement of pulmonary distention pressures. In
the prospective, randomized, controlled trial reported
by the ARDS Network, 861 patients were placed on
either low VT (6 mL/kg PBW) with plateau pressures
Emergency Medicine Practice 2008
Intrinsic PEEP/Auto-PEEP
The presence of airflow at end-expiration indicates that
the alveolar pressure is higher than the atmospheric
pressure or higher than the applied PEEP.44,45 The
pressure difference associated with the trapped volume
is called intrinsic PEEP or auto-PEEP. Auto-PEEP is the
average pressure inside the alveoli at end-exhalation.
Elevated intrathoracic pressure due to auto-PEEP
can decrease cardiac output and blood pressure by
impeding venous return and right ventricular filling.
This will result in increasing pulmonary vascular
resistance and increasing preload and afterload of the
left ventricle (Figure 8).91
12
13
14
Cutting Edge
Measuring And Applying The P-Flex
The steepest part of the curve reflects the best recruitable lung.
Upper Inflection
Point (UIP)
V
O
L
Volume
Low compliance
decreased Volume/
pressure
P-flex
High compliance
Increased Volume/
pressure
Low compliance
decreased Volume/
pressure
Lower Inflection
Point (LIP)
10
15
20
25
30
Pressure
Press
15
Summary
Ventilators are life-saving machines, but they must
be used properly. Just as they can save lives, they can
cause significant and irreparable damage to a patient if
used improperly. In this article, the basics of ventilator
management were discussed for 3 common causes
of respiratory failure in the ED. While respiratory
decompensation was the common theme, each disease
process is marked by unique pathophysiology. An
understanding of the diseases, their pathophysiology,
and the ventilator basics presented here will allow for
confident management of difficult patients.
Asthma is a major health concern in the United
States. This disease affects both young and old, and it
can rapidly lead to respiratory insufficiency and arrest.
The underlying issue involves obstruction of the lower
airway with inflammation, mucous, and airway spasm.
Ventilatory management must be approached carefully
and individualized to each case. Adequate sedation
is the first step. This will allow a tired patient to rest
Emergency Medicine Practice 2008
16
Case Conclusions
Case #1: You intubate the young asthmatic and start her
on pressure control ventilation. She is adequately sedated
and paralyzed as you obtain your initial settings. Because
of severe obstruction and prolonged expiratory phase, you
have the following settings: FIO2 100% and PCAC to achieve
target tidal volume of 400 mL. The inspiratory occlusion
maneuver reveals an acceptable plateau pressure of 27 cm
H2O. After initial PEEP of 5, the P-flex suggests you set the
PEEP at 8 cm H2O. The patient is adequately sedated with
ketamine and morphine and therefore tolerates a respiratory
rate of 6 breaths per minute and a short inspiratory time with
a prolonged expiratory time. With these settings, you get an
ABG of pH 7.28, PaO2 85, and PaCO2 of 110. The nurses
are uncomfortable and ask to increase the respiratory rate
and oxygen. Instead, you recognize the role of permissive
hypercapnia and lung protective strategies. The whistling
of the continuous nebs comforts you as you arrange an ICU
admission.
EBMedicine.net August 2008
References
Evidence-based medicine requires a critical appraisal
of the literature based upon study methodology
and number of subjects. Not all references are
equally robust. The findings of a large, prospective,
randomized, and blinded trial should carry more
weight than a case report.
To help the reader judge the strength of each
reference, pertinent information about the study,
such as the type of study and the number of patients
in the study, will be included in bold type following
the reference, where available. In addition, the
most informative references cited in this paper, as
determined by the authors, will be noted by an asterisk
(*) next to the number of the reference.
1. American Lung Association. Epidemiology and statistics Unit, Research
and Program Services. Trends in Asthma Morbidity and Mortality May
2005. (Consensus opinion)
2. Pappas G, Hadden W, Kozak L, et al. Potentially avoidable
hospitalizations: inequalities in rates between US socioeconomic
groups. Am J Public Health 1997;87:811-816 (Retrospective; 192,734
hospitalizations)
3. Weiss KB, Gergen PG, Hodgson TA. An economic evaluation of asthma
in the United States. N Engl J Med 1992;326:862-866 (Retrospective)
4. New Asthma Estimates: tracking Prevalence, Health Care and
Mortality, NCHS, CDC, 2001 (Consensus opinion)
5. Centers for Disease Control and Prevention. Forecasted state-specific
estimates of self-reported asthma prevalence- Unites States 1998.
MMWR Morb Mortal Wkly Rep 1998; 47:1022-1025 (Retrospective)
6. Pendergraft T, Stanford R, Beasley R, et al. Rates and characteristics
of intensive care unit admissions and intubations among asthmarelated hospitalizations. Ann Allergy Asthma Immunol 2004;93:29-35
(Comparative analysis)
17
7. Kearney SE, Graham DR, Atherton ST: Acute severe asthma treated by
mechanical ventilation: a comparison of the changing characteristics over
a 17 year period. Respir Med 1998;92:716-721 (Comparative analysis)
8. Pauwels R, Buist A, Ma P, et al. Global strategy for the diagnosis,
management, and prevention of chronic obstructive pulmonary disease:
National Heart, and Lung Blood Institute and world Health Organization
Global Initiative for COPD(GOLD):executive summary. Respir Care
2001;46(8):798-825 (Consensus development conference, review)
9. National Center for Health Statistics. National Health Interview Survey:
Research for the 1995-2004 redesign. Hyattsville, MD: U.S. Department of
Health and Human Services, CDC, NCHS Vital and Health Stat 1999;2:126
(Consensus opinion)
10. National Center for Health Statistics. National Hospital Ambulatory
Medical Care Survey. Hyattsville, MD: U.S. Department of Health and
Human Services, CDC, NCHS 1995-2000 (Consensus opinion)
11. National Heart, Lung, and Blood Institute. Chronic obstructive pulmonary
disease. Bethesda, MD: U.S. Department of Health and Human Services,
NIH, NHLBI March 2003 (Expert guidelines)
12. National Heart, Lung, And Blood Institute. Morbidity and Mortality: 2002
Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD:
U.S. Department of Health and Human Services, NIH, NHLBI May 2002
(Textbook)
13. National Heart, Lung, and Blood Institute. Congestive Heart Failure Data
Fact Sheet: NHLBI 2001 (Review)
14. National Center for Chronic Disease Prevention & Health Promotion.
Facts about congestive heart failure.CDC, Division of Media Relations
2001 (Retrospective)
15. Burt C, Schappert S. Ambulatory care visits to physician offices, hospital
outpatient departments and emergency departments: United Sates 2000.
Vital Health Stat 2004;(13)157:1-70 (Review)
16. Centers for Medicare and Medicaid Services. Health Care Financing
Review: Medicare and Medicaid Statistical Supplement. Baltimore, MD:
Centers for Medicare and Medicaid Services 2003 (Cost analysis)
17. Bott J, carroll MP, Conway JH, et al. Randomized, controlled trial of nasal
ventilation in acute ventilatory failure due to chronic obstructive airway
disease. Lancet 1993;341:1555-1557 (Prospective, randomized, control, 60
patients)
18. Brochard L, Mancebo J, Wysocki M, et al. Non-invasive ventilation for
acute exacerbations of chronic obstructive pulmonary disease. N Engl J
Med 1995;333:817-822 (Prospective, randomized, control 85 patients)
19. Kramer N, Meyer TJ, Meharg J, et al. Randomized, prospective trial of
non-invasive positive pressure ventilation in acute respiratory failure. Am
j Respir Crit Care Med 1995;151:1799-1806 (Prospective, randomized, 31
patients)
20. Martin T, Hovis J, Costantino J, et al. A randomized, prospective
evaluation of non-invasive ventilation for acute respiratory failure.
Am J Respir Crit Care Med 2000;161:807-813 (Prospective, comparative,
randomized, control, 61 patients)
21. Antonelli M, Conti G, Rocco M, et al. A comparison of non-invasive
postive pressure ventilation and conventional mechanical ventilation
in patients with acute respiratory failure. N Engl J Med 1998;339:429-435
(Randomized control 64 patients)
22. Masip J, Roque M, Sanchez B, et al. Noninvasive ventilation in acute
cardiogenic pulmonary edema; systematic review and meta-analysis.
JAMA 2005;294(2):3124-3130 (Randomized, control, 40 patients)
23. Meduri G, Cook T, Turner R, et al. Noninvasive positive pressure
ventilation in status asthmaticus. Chest 1996;110(3):767-774 (Prospective,
17 patients)
24. Soroksky A, Stav D, Shipirer I. A pilot prospective, randomized placebocontrolled trial of bilevel positive airway pressure in acute asthmatic
attack. Chest 2003;123(4):1018-1025 (Prospective, randomized control, 30
patients)
25. Peter J, Moran J, Phillips-Hughes J, et al. Noninvasive ventilation in acute
respiratory failure- a meta-analysis update. Crit Care Med 2002;30:555-562
(Meta-analysis, 15 articles)
26. Evans T. International consensus conferences in intensive care medicine:
non-invasive positive pressure ventilation in acute respiratory failure.
Intensive Care Med 2001;27:166-178 (Consensus, conference review)
27. Meduri G, Turner R, Abou-Shala N, et al. Noninvasive positive pressure
ventilation via face mask: first-line intervention in patients with acute
hypercapnic and hypoxemic respiratory failure. Chest 1996;109:179-193
(Prospective, uncontrolled, 158 patients)
28. Mehta S, Hill N. Noninvasive ventilation. Am J Respir Crit Care Med
2001;163: 540-577 (Review)
29 Lightowler JV, Wedzicha JA, Elliot MW, Ram FS. Noninvasive
positive pressure ventilation to treat respiratory failure resulting from
exacerbations of chronic obstructive pulmonary disease: Cochrane
systematic review and meta-analysis. BMJ 2003;326:185-187 (Systematic
review, 8 articles)
30. Wood K, Lewis L, VonHarz B, et al. The use of noninvasive positive
pressure ventilation in the emergency department: results of a
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
18
CME Questions
19
Announcements
Date of Original Release: August 1, 2008. Date of most recent review: June 11,
2008. Termination date: August 1, 2011.
Accreditation: This activity has been planned and implemented in accordance
with the Essentials and Standards of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of Mount Sinai School
of Medicine and Emergency Medicine Practice. The Mount Sinai School of
Medicine is accredited by the ACCME to provide continuing medical education
for physicians.
Credit Designation: The Mount Sinai School of Medicine designates this
educational activity for a maximum of 48 AMA PRA Category 1 Credit(s) per
year. Physicians should only claim credit commensurate with the extent of their
participation in the activity.
ACEP Accreditation: Emergency Medicine Practice is approved by the American
College of Emergency Physicians for 48 hours of ACEP Category 1 credit per
annual subscription.
AAFP Accreditation: Emergency Medicine Practice has been reviewed and is
acceptable for up to 48 Prescribed credits per year by the American Academy of
Family Physicians. AAFP Accreditation begins August 1, 2008. Term of approval
is for two years from this date. Each issue is approved for 4 Prescribed credits.
Credits may be claimed for two years from the date of this issue.
AOA Accreditation: Emergency Medicine Practice has been approved for 48
Category 2B credit hours per year by the American Osteopathic Association.
Needs Assessment: The need for this educational activity was determined by a
survey of medical staff, including the editorial board of this publication; review
of morbidity and mortality data from the CDC, AHA, NCHS, and ACEP; and
evaluation of prior activities for emergency physicians.
Target Audience: This enduring material is designed for emergency medicine
physicians, physician assistants, nurse practitioners, and residents.
Goals & Objectives: Upon completion of this article, you should be able to: (1)
demonstrate medical decision-making based on the strongest clinical evidence;
(2) cost-effectively diagnose and treat the most critical ED presentations; and (3)
describe the most common medicolegal pitfalls for each topic covered.
Discussion of Investigational Information: As part of the newsletter, faculty may
be presenting investigational information about pharmaceutical products that is
outside Food and Drug Administration-approved labeling. Information presented
as part of this activity is intended solely as continuing medical education and is
not intended to promote off-label use of any pharmaceutical product. Disclosure
of Off-Label Usage: This issue of Emergency Medicine Practice discusses no
off-label use of any pharmaceutical product.
Faculty Disclosure: It is the policy of Mount Sinai School of Medicine to ensure
objectivity, balance, independence, transparency, and scientific rigor in all
CME-sponsored educational activities. All faculty participating in the planning
or implementation of a sponsored activity are expected to disclose to the
audience any relevant financial relationships and to assist in resolving any conflict
of interest that may arise from the relationship. Presenters must also make
a meaningful disclosure to the audience of their discussions of unlabeled or
unapproved drugs or devices.
In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty
for this CME activity were asked to complete a full disclosure statement. The
information received is as follows: Dr. White, Dr. DeGiorgi, Dr. DeBlieux, and
Dr. Weingart report no significant financial interest or other relationship
with the manufacturer(s) of any commercial product(s) discussed in this
educational presentation. Dr. Murphy is a shareholder in The Airway Site.
Method of Participation:
Print Subscription Semester Program: Paid subscribers who read all CME
articles during each Emergency Medicine Practice six-month testing period,
complete the post-test and the CME Evaluation Form distributed with the June
and December issues, and return it according to the published instructions are
eligible for up to 4 hours of CME credit for each issue. You must complete both
the post test and CME Evaluation Form to receive credit. Results will be kept
confidential. CME certificates will be delivered to each participant scoring higher
than 70%.
Online Single-Issue Program: Current, paid subscribers who read this
Emergency Medicine Practice CME article and complete the online post-test
and CME Evaluation Form at ebmedicine.net are eligible for up to 4 hours of
Category 1 credit toward the AMA Physicians Recognition Award (PRA). You
must complete both the post-test and CME Evaluation Form to receive credit.
Results will be kept confidential. CME certificates may be printed directly from
the website to each participant scoring higher than 70%.
Hardware/Software Requirements: You will need a Macintosh or PC to access the
online archived articles and CME testing. Adobe Reader is required to view the
PDFs of the archived articles. Adobe Reader is available as a free download at
www.adobe.com.
Emergency Medicine Practice is not affiliated with any pharmaceutical firm or medical device manufacturer.
President and Publisher: Stephanie Williford Associate Editor & CME Director: Jennifer Pai
Director of Member Services: Liz Alvarez
EB Medicine
1-800-249-5770
Outside the U.S.: 1-678-366-7933
Fax: 1-770-500-1316
5550 Triangle Parkway, Suite 150
Norcross, GA 30092
E-mail: ebm@ebmedicine.net
Web Site: ebmedicine.net
Subscription Information:
1 year (12 issues) including evidence-based print issues, 48
AMA/ACEP Category 1, AAFP Prescribed, or AOA Category 2B
CME credits, and full online access to searchable archives and
additional CME: $329
1 year institutional/hospital/library rate: $899
Individual issues, including 4 CME credits: $30
(Call 1-800-249-5770 or go to www.empractice.com to order)
Opinions expressed are not necessarily those of this publication. Mention of products or services does not constitute endorsement. This publication is intended as a general guide and
is intended to supplement, rather than substitute, professional judgment. It covers a highly technical and complex subject and should not be used for making specific medical decisions.
The materials contained herein are not intended to establish policy, procedure, or standard of care. Emergency Medicine Practice is a trademark of EB Practice, LLC. Copyright 2008 EB
Practice, LLC. All rights reserved. No part of this publication may be reproduced in any format without written consent of EB Practice, LLC. This publication is intended for the use of the
individual subscriber only, and may not be copied in whole or part or redistributed in any way without the publishers prior written permissionincluding reproduction for educational purposes
or for internal distribution within your hospital, library, group practice, or other entity.
20